Log in to save to my catalogue

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resist...

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resist...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2194145899

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

About this item

Full title

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

Publisher

England: Future Medicine Ltd

Journal title

Future oncology (London, England), 2019-04, Vol.15 (10), p.1115-1123

Language

English

Formats

Publication information

Publisher

England: Future Medicine Ltd

More information

Scope and Contents

Contents

To evaluate activity of metronomic cyclophosphamide (mCTX) in heavily pretreated metastatic castration-resistant prostate cancer (mCRPC) patients.
We retrospectively evaluated a consecutive series of 74 mCRPC patients treated with at least one new agent after docetaxel failure, who received once-daily oral mCTX treatment at a fixed dose of 50 mg...

Alternative Titles

Full title

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2194145899

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2194145899

Other Identifiers

ISSN

1479-6694

E-ISSN

1744-8301

DOI

10.2217/fon-2018-0715

How to access this item